Mark Conley

2 weeks ago | medicalxpress.com | Mark Conley

Ozempic and similar semaglutide-based medications have been hailed as miracle drugs. Known as GLP-1 (glucagon-like peptide-1) agonists, this class of medications mimics a natural hormone the small intestine releases after you eat. They slow the movement of food through the gut and boost insulin production, increasing the feeling of fullness and suppressing appetite.

3 weeks ago | scopeblog.stanford.edu | Mark Conley |Krista Conger

Ozempic and similar semaglutide-based medications have been hailed as miracle drugs. Known as GLP-1 (glucagon-like peptide-1) agonists, this class of medications mimics a natural hormone the small intestine releases after you eat. They slow the movement of food through the gut and boost insulin production, increasing the feeling of fullness and suppressing appetite.

2 months ago | scopeblog.stanford.edu | Ruthann Richter |Margarita Gallardo |Mark Conley

Four years ago, celebrated cellist Joshua Roman was returning from a performance in Florida when he collapsed in tears on the stairs to his New York home, unable to take another step. A bout with COVID-19 left him so debilitated that at times he could barely lift his cello bow or even open his eyes and speak. "I would have this sudden onset of violent shaking and not know why. I still have that but it's much less often," he said recently.

Nov 21, 2024 | scopeblog.stanford.edu | Hanae Armitage |Margarita Gallardo |Mark Conley

Around 1.5 billion people globally experience some level of hearing loss -- that's nearly 20% of the world's population. Losing the ability to hear can be devastating, and navigating the potential treatments isn't always straight forward. What actually causes it? Are there new treatments that can restore hearing? Can it be reversed? How does air travel affect hearing loss?

Oct 16, 2024 | scopeblog.stanford.edu | Margarita Gallardo |Mark Conley |Krista Conger

In his nearly two decades as a clinical professor at Stanford Medicine, Bryant Lin had never stood before a classroom of students as a patient -- let alone as a patient who, despite never inhaling "a single puff of smoke of any kind," has been afflicted with an incurable form of late-stage lung cancer. Therefore, it was little surprise when the focus of lesson No. 1 in his new fall class swerved toward Lin's tear ducts rather than his lungs. "I was hoping not to get choked up...